MYL12A

MYL12A is a non-muscle myosin II regulatory light chain that associates with heavy chains MYH9 and MYH10 and is required for holoenzyme stability, as depletion of MYL12A and its paralogs dramatically reduces heavy-chain and essential-light-chain protein levels and disrupts cell morphology (PMID:21126233). Phosphorylation of MYL12A at Ser19/Thr20 by smooth-muscle MLCK or by the Salmonella effector kinase SteC activates actomyosin contractility, driving processes ranging from cochlear hair cell apical constriction and mechanosensory hair bundle stiffness to macrophage migration during bacterial infection (PMID:33877471, PMID:38528181, PMID:40240732). MYL12A protein stability is regulated by the deubiquitinase OTUD3, which opposes its ubiquitin-dependent degradation, and by the necdin–SGT1–HSP90 chaperone axis, loss of which causes cardiac dysfunction that is rescued by cardiac-specific MYL12A overexpression (PMID:39097608, PMID:38832028). Despite colocalization and shared phosphorylation sites with paralogs MYL12B and MYL9, MYL12A is functionally distinct: it cannot rescue the cell-spreading defect caused by collective MRLC depletion, likely owing to its unique N-terminal sequence (PMID:26663899).

1. 2011 High

   Establishing that RLCs are essential structural subunits of the NM II holoenzyme resolved whether MYL12A functions merely as a regulatory switch or is required for heavy-chain stability itself.

   Evidence Co-IP/MS proteomics and siRNA knockdown in NIH 3T3 fibroblasts showing loss of MYH9, MYH10, and MYL6 upon MYL12A/12B depletion

   PMID:21126233

   Open questions at the time

   • Individual contributions of MYL12A versus MYL12B to holoenzyme stabilization were not separated
   • Mechanism of heavy-chain degradation upon RLC loss (proteasomal vs. autophagic) was not determined
2. 2015 Medium

   Demonstrating that MYL12A cannot rescue collective MRLC-depletion phenotypes while MYL12B and MYL9 can established isoform-specific functional divergence despite shared phosphosites.

   Evidence siRNA depletion/overexpression rescue of cell spreading in HeLa cells, FRAP turnover analysis, and structural modeling of the unique MYL12A N-terminus

   PMID:26663899

   Open questions at the time

   • The molecular basis for the functional difference (N-terminal orientation model) lacks experimental structural validation
   • Whether MYL12A has unique interactors not shared by MYL12B is unexplored
3. 2021 Medium

   Identifying smMLCK-dependent phosphorylation of MYL12 in cochlear hair cells linked RLC phosphorylation to a specific mechanosensory tissue, revealing that actomyosin contractility governs hair cell apical geometry.

   Evidence In vitro kinase assay with purified MYL12B, ML-7 pharmacological inhibition with outer hair cell apical area measurement

   PMID:33877471

   Open questions at the time

   • The kinase assay used MYL12B substrate; direct phosphorylation of MYL12A by smMLCK was not separately confirmed
   • Genetic loss-of-function for MYL12A in hair cells was not performed
4. 2024 High

   Solving the SteC crystal structure and demonstrating direct phosphorylation of MYL12A at Ser19/Thr20 revealed how a bacterial pathogen hijacks host actomyosin contractility to breach the gut-vascular barrier.

   Evidence In vitro kinase assays with phospho-site mapping, SteC crystal structure, macrophage migration/invasion assays, and in vivo Salmonella infection model

   PMID:38528181

   Open questions at the time

   • Whether SteC also phosphorylates MYL12B/MYL9 with equal efficiency in vivo is unresolved
   • Host kinase contributions (e.g. ROCK, MLCK) relative to SteC during infection were not quantified
5. 2024 High

   Showing that necdin stabilizes MYL12A via the SGT1–HSP90 chaperone axis, with cardiac-specific MYL12A overexpression rescuing heart dysfunction in necdin-knockout mice, placed MYL12A downstream of a Prader-Willi syndrome gene product in cardiac function.

   Evidence Yeast two-hybrid, Co-IP, cardiac-specific overexpression rescue in mice, zebrafish morpholino knockdown

   PMID:38832028

   Open questions at the time

   • Whether MYL12A is the sole mediator of necdin-dependent cardiac function or MYL12B also contributes was not fully resolved
   • The ubiquitin ligase responsible for MYL12A degradation in the absence of necdin/chaperone was not identified
6. 2024 Medium

   Identification of OTUD3 as a deubiquitinase that directly stabilizes MYL12A connected its post-translational turnover to a cancer-relevant signaling axis in DLBCL.

   Evidence Co-IP, ubiquitination assays, siRNA knockdown, competitive inhibition by Rupatadine in DLBCL models

   PMID:39097608

   Open questions at the time

   • The specific ubiquitin linkage type on MYL12A targeted by OTUD3 was not characterized
   • Whether OTUD3-dependent MYL12A stabilization affects actomyosin contractility or operates through a non-canonical pathway was not tested
   • Findings are from a single laboratory
7. 2025 Medium

   Localizing NM2A and MYL12A within hair bundles and showing that NM2/MLCK inhibition reduces bundle stiffness and alters mechanotransduction channel gating extended MYL12A's role from apical geometry to the core mechanosensory transduction apparatus.

   Evidence Immunostaining of hair bundles, pharmacological NM2/MLCK inhibition with stiffness and electrophysiological measurements, auditory brainstem responses in mice

   PMID:40240732

   Open questions at the time

   • Genetic ablation of MYL12A specifically in hair cells has not been reported
   • Relative contributions of MYL12A versus MYL12B to bundle stiffness are unknown

• The E3 ubiquitin ligase(s) targeting MYL12A for proteasomal degradation remain unidentified, and no structural model of MYL12A bound to the NM II heavy-chain lever arm exists to explain its isoform-specific behavior.
• No high-resolution structure of MYL12A in complex with NM II heavy chain
• E3 ligase mediating MYL12A ubiquitination is unknown
• Isoform-specific in vivo phenotypes (MYL12A vs MYL12B knockout) have not been systematically compared